A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice

Science Translational Medicine

Volumn 9, Issue 380, 2017, Pages

  Chiaro, Tyson R ^a   Soto, Ray ^a   Stephens, W Zac ^a   Kubinak, Jason L ^a   Petersen, Charisse ^a   Gogokhia, Lasha ^a   Bell, Rickesha ^a   Delgado, Julio C ^a,b   Cox, James ^a,c   Voth, Warren ^a   Brown, Jessica ^a   Stillman, David J ^a   O'Connell, Ryan M ^a   Tebo, Anne E ^a,b   Round, June L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIBODY; URIC ACID; FUNGUS ANTIBODY; PURINE DERIVATIVE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; DISEASE EXACERBATION; EXPERIMENTAL COLITIS; FEMALE; GERMFREE ANIMAL; HUMAN; INTESTINE MUCOSA PERMEABILITY; MALE; METABOLISM; METABOLOMICS; MOUSE; MOUSE MODEL; NONHUMAN; PURINE METABOLSIM; RHODOTORULA; RHODOTORULA AURANTIACA; SACCHAROMYCES CEREVISIAE; TRANSCRIPTOMICS; URIC ACID BLOOD LEVEL; ANIMAL; BACTERIAL COUNT; BLOOD; C57BL MOUSE; COLITIS; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY; PATHOLOGY; SYMBIOSIS;

ANIMALS; ANTIBODIES, FUNGAL; COLITIS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL MUCOSA; MALE; MICE, INBRED C57BL; PURINES; RHODOTORULA; SACCHAROMYCES CEREVISIAE; SYMBIOSIS; URIC ACID;

EID: 85014918566     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf9044     Document Type: Article

References (57)

1. M. Wlodarska, A. D. Kostic, R. J. Xavier, An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17, 577-591 (2015).
2. D. Gevers, S. Kugathasan, L. A. Denson, Y. Vázquez-Baeza, W. Van Treuren, B. Ren, E. Schwager, D. Knights, S. Jin Song, M. Yassour, X. C. Morgan, A. D. Kostic, C. Luo, A. González, D. McDonald, Y. Haberman, T. Walters, S. Baker, J. Rosh, M. Stephens, M. Heyman, J. Markowitz, R. Baldassano, A. Griffiths, F. Sylvester, D. Mack, S. Kim, W. Crandall, J. Hyams, C. Huttenhower, R. Knight, R. J. Xavier, The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014).
3. D. N. Frank, A. L. St. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, N. R. Pace, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785 (2007).
4. S. K. Mazmanian, J. L. Round, D. L. Kasper, A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
5. reg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
6. L. A. Dieleman, M. S. Goerres, A. Arends, D. Sprengers, C. Torrice, F. Hoentjen, W. B. Grenther, R. B. Sartor, Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52, 370-376 (2003).
7. J. Tang, I. D. Iliev, J. Brown, D. M. Underhill, V. A. Funari, Mycobiome: Approaches to analysis of intestinal fungi. J. Immunol. Methods 421, 112-121 (2015).
8. S. J. Ott, T. Kühbacher, M. Musfeldt, P. Rosenstiel, S. Hellmig, A. Rehman, O. Drews, W. Weichert, K. N. Timmis, S. Schreiber, Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 43, 831-841 (2008).
9. K. Findley, J. Oh, J. Yang, S. Conlan, C. Deming, J. A. Meyer, D. Schoenfeld, E. Nomicos, M. Park; NIH Intramural Sequencing Center Comparative Sequencing Program, H. H. Kong, J. A. Segre, Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367-370 (2013).
10. A. J. Scupham, L. L. Presley, B. Wei, E. Bent, N. Griffith, M. McPherson, F. Zhu, O. Oluwadara, N. Rao, J. Braun, J. Borneman, Abundant and diverse fungal microbiota in the murine intestine. Appl. Environ. Microbiol. 72, 793-801 (2006).
11. M. A. Ghannoum, R. J. Jurevic, P. K. Mukherjee, F. Cui, M. Sikaroodi, A. Naqvi, P. M. Gillevet, Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLOS Pathog. 6, e1000713 (2010).
12. H. Sokol, V. Leducq, H. Aschard, H.-P. Pham, S. Jegou, C. Landman, D. Cohen, G. Liguori, A. Bourrier, I. Nion-Larmurier, J. Cosnes, P. Seksik, P. Langella, D. Skurnik, M. L. Richard, L. Beaugerie, Fungal microbiota dysbiosis in IBD. Gut, 1-10 (2016).
13. M. L. Richard, B. Lamas, G. Liguori, T. W. Hoffmann, H. Sokol, Gut fungal microbiota: The Yin and Yang of inflammatory bowel disease. Inflamm. Bowel Dis. 21, 656-665 (2015).
14. J. D. Lewis, E. Z. Chen, R. N. Baldassano, A. R. Otley, A. M. Griffiths, D. Lee, K. Bittinger, A. Bailey, E. S. Friedman, C. Hoffmann, L. Albenberg, R. Sinha, C. Compher, E. Gilroy, L. Nessel, A. Grant, C. Chehoud, H. Li, G. D. Wu, F. D. Bushman, Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18, 489-500 (2015).
15. D. M. Underhill, I. D. Iliev, The mycobiota: Interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405-416 (2014).
16. D. Underhill, J. Braun, Current understanding of fungal microflora in inflammatory bowel disease pathogenesis. Inflamm. Bowel Dis. 14, 1147-1153 (2008).
17. G. B. Huffnagle, M. C. Noverr, The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-341 (2013).
18. S. Vermeire, S. Joossens, M. Peeters, F. Monsuur, G. Marien, X. Bossuyt, P. Groenen, R. Vlietinck, P. Rutgeerts, Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 120, 827-833 (2001).
19. B. Ursing, T. Alm, F. Bárány, I. Bergelin, K. Ganrot-Norlin, J. Hoevels, B. Huitfeldt, G. Järnerot, U. Krause, A. Krook, B. Lindström, O. Nordle, A. Rosén, A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology 83, 550-562 (1982).
20. C. Prantera, F. Zannoni, M. L. Scribano, E. Berto, A. Andreoli, A. Kohn, C. Luzi, An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am. J. Gastroenterol. 91, 328-332 (1996).
21. L. Sutherland, J. Singleton, J. Sessions, S. Hanauer, E. Krawitt, G. Rankin, R. Summers, H. Mekhjian, N. Greenberger, M. Kelly, Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32, 1071-1075 (1991).
22. S. Lal, A. H. Steinhart, Antibiotic therapy for Crohn's disease: A review. Can. J. Gastroenterol. 20, 651-655 (2006).
23. R. Trenschel, R. Peceny, V. Runde, A. Elmaagacli, H. Dermoumi, E. Heintschel von Heinegg, K.-D. Müller, U. W. Schaefer, D. W. Beelen, Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant. 26, 993-997 (2000).
24. G. Samonis, A. N. Margioris, P. Toloudis, M. Dassiou, S. Maraki, Y. Tselentis, Murine yeast gut flora affected by tetracycline, metronidazole and norfloxacin. J. Chemother. 6, 408-411 (1994).
25. M. C. Noverr, R. M. Noggle, G. B. Toews, G. B. Huffnagle, Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72, 4996-5003 (2004).
26. Dermot P. B. McGovern, A. Gardet, L. Törkvist, P. Goyette, J. Essers, K. D. Taylor, B. M. Neale, Rick T. H. Ong, C. Lagacé, C. Li, T. Green, C. R. Stevens, C. Beauchamp, P. R. Fleshner, M. Carlson, M. D'Amato, J. Halfvarson, M. L. Hibberd, M. Lördal, L. Padyukov, A. Andriulli, E. Colombo, A. Latiano, O. Palmieri, E.-J. Bernard, C. Deslandres, D. W. Hommes, D. J. de Jong, P. C. Stokkers, R. K. Weersma, The NIDDK IBD Genetics Consortium, Y. Sharma, M. S. Silverberg, J. H. Cho, J. Wu, K. Roeder, S. R. Brant, L. Phillip Schumm, R. H. Duerr, M. C. Dubinsky, N. L. Glazer, T. Haritunians, A. Ippoliti, G. Y. Melmed, D. S. Siscovick, E. A. Vasiliauskas, S. R. Targan, V. Annese, C. Wijmenga, S. Pettersson, J. I. Rotter, R. J. Xavier, M. J. Daly, J. D. Rioux, M. Seielstad, Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42, 332-337 (2010).
27. A. Franke, D. P. B. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, C. A. Anderson, J. C. Bis, S. Bumpstead, D. Ellinghaus, E. M. Festen, M. Georges, T. Green, T. Haritunians, L. Jostins, A. Latiano, C. G. Mathew, G. W. Montgomery, N. J. Prescott, S. Raychaudhuri, J. I. Rotter, P. Schumm, Y. Sharma, L. A. Simms, K. D. Taylor, D. Whiteman, C. Wijmenga, R. N. Baldassano, M. Barclay, T. M. Bayless, S. Brand, C. Büning, A. Cohen, J.-F. Colombel, M. Cottone, L. Stronati, T. Denson, M. De Vos, R. D'Inca, M. Dubinsky, C. Edwards, T. Florin, D. Franchimont, R. Gearry, J. Glas, A. Van Gossum, S. L. Guthery, J. Halfvarson, H. W. Verspaget, J.-P. Hugot, A. Karban, D. Laukens, I. Lawrance, M. Lemann, A. Levine, C. Libioulle, E. Louis, C. Mowat, W. Newman, J. Panés, A. Phillips, D. D. Proctor, M. Regueiro, R. Russell, P. Rutgeerts, J. Sanderson, M. Sans, F. Seibold, A. H. Steinhart, P. C. F. Stokkers, L. Torkvist, G. Kullak-Ublick, D. Wilson, T. Walters, S. R. Targan, S. R. Brant, J. D. Rioux, M. D'Amato, R. K. Weersma, S. Kugathasan, A. M. Griffiths, J. C. Mansfield, S. Vermeire, R. H. Duerr, M. S. Silverberg, J. Satsangi, S. Schreiber, J. H. Cho, V. Annese, H. Hakonarson, M. J. Daly, M. Parkes, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
28. B. Ferwerda, G. Ferwerda, T. S. Plantinga, J. A. Willment, A. B. van Spriel, H. Venselaar, C. C. Elbers, M. D. Johnson, A. Cambi, C. Huysamen, L. Jacobs, T. Jansen, K. Verheijen, L. Masthoff, S. A. Morré, G. Vriend, D. L. Williams, J. R. Perfect, L. A. Joosten, C. Wijmenga, J. W. van der Meer, G. J. Adema, B. J. Kullberg, G. D. Brown, M. G. Netea, Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361, 1760-1767 (2009).
29. I. D. Iliev, V. A. Funari, K. D. Taylor, Q. Nguyen, C. N. Reyes, S. P. Strom, J. Brown, C. A. Becker, P. R. Fleshner, M. Dubinsky, J. I. Rotter, H. L. Wang, D. P. B. McGovern, G. D. Brown, D. M. Underhill, Interactions between commensal fungi and the C-type lectin receptor dectin-1 influence colitis. Science 336, 1314-1317 (2012).
30. H. Sokol, K. L. Conway, M. Zhang, M. Choi, B. Morin, Z. Cao, E. J. Villablanca, C. Li, C. Wijmenga, S. H. Yun, H. N. Shi, R. J. Xavier, Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 145, 591-601.e3 (2013).
31. I. Mukhopadhya, R. Hansen, C. Meharg, J. M. Thomson, R. K. Russell, S. H. Berry, E. M. El-Omar, G. L. Hold, The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 17, 304-310 (2015).
32. S. J. Ott, S. Plamondon, A. Hart, A. Begun, A. Rehman, M. A. Kamm, S. Schreiber, Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J. Clin. Microbiol. 46, 3510-3513 (2008).
33. F. Wirth, L. Z. Goldani, Epidemiology of Rhodotorula: An emerging pathogen. Interdiscip. Perspect. Infect. Dis. 2012, 465717 (2012).
34. S. Wirtz, C. Neufert, B. Weigmann, M. F. Neurath, Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007).
35. A. M. Spees, C. A. Lopez, D. D. Kingsbury, S. E. Winter, A. J. Bäumler, Colonization resistance: Battle of the bugs or Ménage à Trois with the host? PLOS Pathog. 9, e1003730 (2013).
36. I. I. Ivanov, K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, T. Tanoue, A. Imaoka, K. Itoh, K. Takeda, Y. Umesaki, K. Honda, D. R. Littman, Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
37. L. V. Hooper, M. H. Wong, A. Thelin, L. Hansson, P. G. Falk, J. I. Gordon, Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001).
38. D. Hollander, C. M. Vadheim, E. Brettholz, G. M. Petersen, T. Delahunty, J. I. Rotter, Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105, 883-885 (1986).
39. C. W. Teshima, L. A. Dieleman, J. B. Meddings, Abnormal intestinal permeability in Crohn's disease pathogenesis. Ann. N. Y. Acad. Sci. 1258, 159-165 (2012).
40. J. K. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia, S. Pettersson, Host-gut microbiota metabolic interactions. Science 336, 1262-1267 (2012).
41. P. Pacher, A. Nivorozhkin, C. Szabo, Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 58, 87-114 (2006).
42. A. Pantazopoulou, G. Diallinas, Fungal nucleobase transporters. FEMS Microbiol. Rev. 31, 657-675 (2007).
43. S. Desplat-Jégo, C. Johanet, A. Escande, J. Goetz, N. Fabien, N. Olsson, E. Ballot, J. Sarles, J. J. Baudon, J. C. Grimaud, Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study. World J. Gastroenterol. 13, 2312-2318 (2007).
44. S. Ashorn, H. Raukola, T. Välineva, M. Ashorn, B. Wei, J. Braun, I. Rantala, K. Kaukinen, T. Luukkaala, P. Collin, M. Mäki, S. Iltanen, Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J. Clin. Immunol. 28, 486-494 (2008).
45. A. Standaert-Vitse, T. Jouault, P. Vandewalle, C. Mille, M. Seddik, B. Sendid, J.-M. Mallet, J.-F. Colombel, D. Poulain, Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 130, 1764-1775 (2006).
46. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, J. Tschopp, Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
47. J. T. Kratzer, M. A. Lanaspa, M. N. Murphy, C. Cicerchi, C. L. Graves, P. A. Tipton, E. A. Ortlund, R. J. Johnson, E. A. Gaucher, Evolutionary history and metabolic insights of ancient mammalian uricases. Proc. Natl. Acad. Sci. U.S.A. 111, 3763-3768 (2014).
48. S. M. Govani, P. D. R. Higgins, Combination of thiopurines and allopurinol: Adverse events and clinical benefit in IBD. J. Crohns Colitis 4, 444-449 (2010).
49. J. C. Edozien, U. U. Udo, V. R. Young, N. S. Scrimshaw, Effects of high levels of yeast feeding on uric acid metabolism of young man. Nature 228, 180 (1970).
50. T. Danø Klingberg, U. Lesnik, N. Arneborg, P. Raspor, L. Jespersen, Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res. 8, 631-640 (2008).
51. R. de Llanos, S. Llopis, G. Molero, A. Querol, C Gil, M. T. Fernández-Espinar, In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits. Int. J. Food Microbiol. 144, 393-399 (2011).
52. G. S. de Hoog, Risk assessment of fungi reported from humans and animals. Mycoses 39, 407-417 (1996).
53. R. K. Mortimer, P. Romano, G. Suzzi, M. Polsinelli, Genome renewal: A new phenomenon revealed from a genetic study of 43 strains of Saccharomyces cerevisiae derived from natural fermentation of grape musts. Yeast 10, 1543-1552 (1994).
54. B. Posteraro, M. Sanguinetti, G. D'Amore, L. Masucci, G. Morace, G. Fadda, Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. J. Clin. Microbiol. 37, 2230-2235 (1999).
55. T. Drell, T. Lillsaar, L. Tummeleht, J. Simm, A. Aaspõllu, E. Väin, I. Saarma, A. Salumets, G. G. G. Donders, M. Metsis, Characterization of the vaginal microand mycobiome in asymptomatic reproductive-age Estonian women. PLOS ONE 8, e54379 (2013).
56. A. B. Canelas, A. ten Pierick, C. Ras, R. M. Seifar, J. C. van Dam, W. M. van Gulik, J.J. Heijnen, Quantitative evaluation of intracellular metabolite extraction techniques for yeast metabolomics. Anal. Chem. 81, 7379-7389 (2009).
57. J. Xia, R. Mandal, I. V. Sinelnikov, D. Broadhurst, D. S. Wishart, MetaboAnalyst 2.0 - A comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127-W133 (2012).